Latest news
25 items- SECApollo Medical Holdings Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits8-K - Astrana Health, Inc. (0001083446) (Filer)
- NEWSApollo Medical Hlgs Q4 2023 GAAP EPS $0.26 Beats $0.15 Estimate, Sales $353.04M Beat $340.61M EstimateApollo Medical Hlgs (NASDAQ:AMEH) reported quarterly earnings of $0.26 per share which beat the analyst consensus estimate of $0.15 by 73.33 percent. The company reported quarterly sales of $353.04 million which beat the analyst consensus estimate of $340.61 million by 3.65 percent. This is a 20.00 percent increase over sales of $294.21 million the same period last year.
- SECApollo Medical Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Astrana Health, Inc. (0001083446) (Filer)
- NEWSApollo Medical Hlgs's Earnings OutlookApollo Medical Hlgs (NASDAQ:AMEH) is set to give its latest quarterly earnings report on Tuesday, 2024-02-27. Here's what investors need to know before the announcement. Analysts estimate that Apollo Medical Hlgs will report an earnings per share (EPS) of $0.15. Apollo Medical Hlgs bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter. New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast). Past Earnings Performance Last quarter the company beat EPS by $0.14, which was followed by a 9.08% i
- NEWSJefferies Initiates Coverage On Apollo Medical Hlgs with Buy Rating, Announces Price Target of $50Jefferies analyst Jack Slevin initiates coverage on Apollo Medical Hlgs (NASDAQ:AMEH) with a Buy rating and announces Price Target of $50.
- SECApollo Medical Holdings Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits8-K - Astrana Health, Inc. (0001083446) (Filer)
- NEWSApollo shares are trading higher after B of A Securities upgraded the stock from Neutral to Buy and raised its price target from $44 to $55.
- NEWSB of A Securities Upgrades Apollo Medical Hlgs to Buy, Raises Price Target to $55B of A Securities analyst Adam Ron upgrades Apollo Medical Hlgs (NASDAQ:AMEH) from Neutral to Buy and raises the price target from $44 to $55.
- ANALYSTApollo Medical upgraded by BofA Securities with a new price targetBofA Securities upgraded Apollo Medical from Neutral to Buy and set a new price target of $55.00 from $44.00 previously
- NEWSApollo Medical Holdings Announced That It Will Formally Change Its Name From Apollo Medical Holdings, Inc. To Astrana Health, Inc. And Will Begin Trading Under The Ticker Symbol "ASTH", Both Effective February 26, 2024
- PRApollo Medical Holdings, Inc. Becomes Astrana Health, Inc.ALHAMBRA, Calif., Feb. 22, 2024 /PRNewswire/ -- Apollo Medical Holdings, Inc.("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:AMEH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, announced today it will formally change its name from Apollo Medical Holdings, Inc. ("ApolloMed") to Astrana Health, Inc. ("Astrana Health"). As previously announced, the Company will begin trading under the ticker symbol "ASTH." Both changes will take effect February 26, 2024.
- 13D/GSEC Form SC 13G/A filed by Apollo Medical Holdings Inc. (Amendment)SC 13G/A - Apollo Medical Holdings, Inc. (0001083446) (Subject)
- SECApollo Medical Holdings Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits8-K - Apollo Medical Holdings, Inc. (0001083446) (Filer)
- PRApollo Medical Holdings, Inc. Schedules 2023 Fourth Quarter and Full Year Financial Results Release and Conference CallALHAMBRA, Calif., Jan. 31, 2024 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:AMEH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that it will release financial results for the fourth quarter and full year ended December 31, 2023, after the close of the stock market on Tuesday, February 27, 2024. The Company will discuss those results on a conference call at 2:30 p.m. PT/5:30 p.m. ET that same day.
- PRApolloMed and BASS Medical Group to Forge a Value-Based Healthcare PartnershipALHAMBRA, Calif., Jan. 29, 2024 /PRNewswire/ -- Apollo Medical Holdings, Inc.("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:AMEH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced a strategic long-term partnership with BASS Medical Group, one of the largest multi-specialty medical groups in the Greater San Francisco Bay Area. The partnership will bolster BASS Medical Group's value-based care and operational infra
- SECApollo Medical Holdings Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits8-K - Apollo Medical Holdings, Inc. (0001083446) (Filer)
- INSIDERKumar Dinesh M. was granted 150,395 shares (SEC Form 4)4 - Apollo Medical Holdings, Inc. (0001083446) (Issuer)
- INSIDERSEC Form 3 filed by new insider Kumar Dinesh M.3 - Apollo Medical Holdings, Inc. (0001083446) (Issuer)
- SECApollo Medical Holdings Inc. filed SEC Form 8-K: Leadership Update, Other Events8-K - Apollo Medical Holdings, Inc. (0001083446) (Filer)
- NEWSApollo Medical Holdings Inc Says Brandon Sim, Company's Co-CEO, Has Been Named President And Chief Executive Officer, Effective January 19, 2024; Thomas Lam Will Serve As Vice Chairman Of Board Of Directors, Retiring As President And Co-CEO, Effective Jan- SEC Filing
- PRApollo Medical Holdings, Inc. Announces Leadership TransitionsALHAMBRA, Calif., Jan. 24, 2024 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:AMEH), a leading provider-centric, technology-powered healthcare company which enables providers to deliver accessible, high-quality, and high-value care to all, today announced the following leadership transitions: Brandon Sim, the company's Co-CEO, has been named President and Chief Executive Officer, effective January 19, 2024.Dr. Thomas Lam will serve as Vice Chairman of the Board of Directors and is
- PRApollo Medical Holdings, Inc. Announces Planned Corporate Rebrand as Astrana HealthALHAMBRA, Calif., Jan. 24, 2024 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:AMEH), a leading provider-centric, technology-powered healthcare company which enables providers to deliver accessible, high-quality, and high-value care to all, today announced it plans to change its name to Astrana Health, effective February 26, 2024. Alongside the planned corporate name change, the Company's common stock is intended to begin trading under the new symbol "ASTH" on the NASDAQ, effective February 26, 2024.
- PRApollo Medical Holdings, Inc. Announces Grant of Inducement Awards Pursuant to Nasdaq Listing Rule 5635(c)(4)ALHAMBRA, Calif., Jan. 24, 2024 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:AMEH), a leading physician-centric, technology-powered healthcare company focused on enabling providers in the successful delivery of value-based care, today announced that effective on January 23, 2024, the Compensation Committee of ApolloMed's Board of Directors (the "Committee") granted 85,130 shares of time-based restricted common stock and 65,265 shares of performance-based restricted common stock to Dinesh M. Kumar, M.D., the Company's newly-hired Chief Medical Officer, under the Apollo Medical Holdings, Inc. Empl
- ANALYSTStifel initiated coverage on Apollo Medical with a new price targetStifel initiated coverage of Apollo Medical with a rating of Buy and set a new price target of $45.00
- NEWSStifel Initiates Coverage On Apollo Medical Hlgs with Buy Rating, Announces Price Target of $45Stifel analyst Craig Jones initiates coverage on Apollo Medical Hlgs (NASDAQ:AMEH) with a Buy rating and announces Price Target of $45.
AMEH FAQ
6 questionsWhat does Apollo Medical Holdings Inc. do?
Apollo Medical Holdings, Inc., a physician-centric technology-powered healthcare management company, provides medical care services. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network...Where does AMEH stock trade?
Apollo Medical Holdings Inc. (AMEH) is listed on NASDAQ.What sector and industry is AMEH in?
Apollo Medical Holdings Inc. operates in the Consumer Discretionary sector, Professional Services industry.What are analysts saying about AMEH?
Apollo Medical Holdings Inc. has had 8 recent analyst actions on file. The most recent action was from BofA Securities: Buy on 2024-02-22. Recent price targets range from $4000.00 to $4500.00.What companies are similar to AMEH?
Notable peers in the same industry include GIB (CGI Inc.), BAH (Booz Allen Hamilton Holding Corporation), ASGN (ASGN Incorporated), G (Genpact Limited), FCN (FTI Consulting Inc.). Compare AMEH side-by-side with any of them on Quantisnow.How can I track AMEH on Quantisnow?
Quantisnow aggregates Apollo Medical Holdings Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow AMEH to receive live email and push alerts on every new disclosure.